510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K802886Substantially Equivalent

Nucli-Pap Tm-(I125)-Pap Radioimmunoas-

Nuclear Diagnostics, Inc., Mchenry IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K802886 is the FDA 510(k) clearance record for NUCLI-PAP TM-(I125)-PAP RADIOIMMUNOAS-, a class II device, cleared for Nuclear Diagnostics, Inc. on under FDA product code JFH (Acid Phosphatase (Prostatic), Tartrate Inhibited). FDA records list 24 510(k) clearances for Nuclear Diagnostics, Inc., from to . As of , FDA records show no recalls naming K802886.

Clearance record

Decision date
Received
(72 days to decision)
Product code
JFH Acid Phosphatase (Prostatic), Tartrate Inhibited
Regulation
21 CFR 862.1020
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Nuclear Diagnostics, Inc. 803 N. Front St. Suite 3, Mchenry IL
Third party review
No

Clearances, product code JFH

Trailing 12 months

FDA records hold no clearances under product code JFH in the trailing twelve months.

FDA records show no clearances under product code JFH in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JFH, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260